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a-1-Antitrypsin and IFN-c Reduce the Severity
of IC-Mediated Vasculitis by Regulation of
Leukocyte Recruitment In Vivo
Micha Feld1,5, Tobias Goerge1,2,5, Carina Hillgruber1, Annika Kathrin Steingra¨ber1, Michaela Fastrich1,
Victoria Shpacovitch1,3 and Martin Steinhoff4
IC-mediated vasculitis (ICV) can be life threatening. The cellular and immune mechanisms controlling ICV are
poorly understood. Therefore, we investigated the role of a-1-antitrypsin (a1AT) and IFN-g in reducing the
severity of ICV in a mouse model in vivo. To induce ICV, mice were challenged with the reverse passive Arthus
reaction (RPA), the prototypic in vivo model for leukocytoclastic vasculitis (LcV), and the modulation of vascular
permeability, edema formation, and leukocyte recruitment was studied. To further analyze the dynamics of RPA,
we applied intravital microscopy in the dorsal skinfold chamber. a1AT continuously led to reduced leukocyte
recruitment. a1AT interfered with neutrophil recruitment through a KC-dependent mechanism and reduced
KC-elicited neutrophil activation. In contrast to a1AT, IFN-g-reduced leukocyte recruitment during RPA was
clearly independent of KC. We also revealed that the recruitment of neutrophils during RPA was a prerequisite
for full KC expression. Thus, therapeutic administration of a1AT and IFN-g might be beneficial for limiting the
duration and severity of ICV.
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INTRODUCTION
Immune complex (IC)–mediated inflammation is a hallmark
in a variety of human diseases including, e.g. systemic lupus
erythematosus, rheumatoid arthritis, and leukocytoclastic
vasculitis (LcV) (Kaburagi et al., 2002; Tsuboi et al., 2008).
In LcV and the reverse passive Arthus reaction (RPA), the
prototypic mouse model for LcV, the formation and deposi-
tion of antigen–antibody ICs mediate the infiltration of
leukocytes, with subsequent tissue damage (Lotti et al.,
1998; Lee and Kavanaugh, 2006). Studies investigating the
molecular basis of RPA revealed that among others neutro-
phil recruitment depends on mast cell Fcg receptors
(Sylvestre and Ravetch, 1996; Ravetch and Bolland, 2001),
L-selectin, and ICAM-1 (Kaburagi et al., 2002), and is, at least
in part, controlled by platelets (Hara et al., 2010).
LcV can be self-limiting and resolve spontaneously
(Lamprecht and Gross, 2011), whereas persisting forms of
LcV can be life threatening and may require immunosup-
pressive treatment. However, therapeutic management of
LcV so far relies on the application of potent, but unspecific,
glucocorticosteroids (Sunderko¨tter, 2009; Khasnis and Lang-
ford, 2009), which may have severe side effects.
The clinical observation of mild, self-limited LcV forms led
us to hypothesize that apart from a discontinued exposure of
the triggering factor, the inflammatory response is under the
control of endogenous factors. This may be due to either a
direct effect of anti-inflammatory mediators on endothelial
cells or through regulation of major pro-inflammatory path-
ways such as neutrophil recruitment through IL-8 (human) or
KC (mouse). Indeed, several in vitro studies revealed negative
regulation of IL-8 and KC through two distinct endogenous
mediators: a-1-antitrypsin (a1AT) and IFN-g (Flesch et al.,
1998; Boost et al., 2008; Pott et al., 2009). However, whether
a1AT or IFN-g reduces KC levels or functions in IC-mediated
vasculitis (ICV) remains unexplored.
Very recently, the protease inhibitor a1AT was shown to
function as an immune modulator, regulating neutrophil
function. a1AT was found to interfere with IL-8- and IC-
induced chemotaxis through binding of IL-8 and controlling
membrane expression of FcgRIIIb, respectively (Bergin et al.,
ORIGINAL ARTICLE
2286 Journal of Investigative Dermatology (2012), Volume 132 & 2012 The Society for Investigative Dermatology
Received 28 September 2011; revised 2 March 2012; accepted 7 March
2012; published online 10 May 2012
1Department of Dermatology and Boltzmann Institute for Immunobiology of
the Skin, University of Mu¨nster, Mu¨nster, Germany; 2Interdisciplinary Center
for Clinical Research (IZKF), University of Mu¨nster, Mu¨nster, Germany;
3ISAS, Leibniz-Institute for Analytical Sciences, Dortmund, Germany and
4Departments of Dermatology and Surgery, University of California,
San Francisco, San Francisco, California, USA
Correspondence: Current address: Micha Feld, Department of Dermatology,
Heinrich-Heine University, Moorenstrasse 5, 40225 Du¨sseldorf, Germany.
E-mail: micha.feld@med.uni-duesseldorf.de or Martin Steinhoff, Departments
of Dermatology and Surgery, University of California, San Francisco, 1701
Divisadero Street, San Francisco, California 94115, USA.
E-mail: steinhoffm@derm.ucsf.edu
5These authors contributed equally to this work.
Abbreviations: AAV, anti-neutrophil cytoplasmic antibody-associated
vasculitis; a1AT, a-1-antitrypsin; DSC, dorsal skinfold chamber; IC, immune
complex; ICV, IC-mediated vasculitis; i.v., intravenous; IVM, intravital
microscopy; LcV, leukocytoclastic vasculitis; MPO, myeloperoxidase;
RPA, reverse passive Arthus reaction
2010). Furthermore, oxidized a1AT, an important component
of inflammatory exudates, downregulates IL-8 expression
(Subramaniyam et al., 2008).
In AAV (anti-neutrophil cytoplasmic antibody-associated
vasculitis), increased IFN-g levels are associated with the
remission of disease (Hruskova et al., 2009). Although AAV is
not primarily mediated through formation of ICs, both AAV
and ICV show massive tissue infiltration by neutrophils
(Calderwood et al., 2005), probably in response to IL-8 or KC
action.
Therefore, the identification of immune regulators that
are also expressed endogenously—potentially modifying
the severity of LcV—is of exciting importance for
effective treatment of LcV in humans. Therefore, the aim
of this study was to evaluate the role of a1AT and IFN-g as
regulators of leukocyte recruitment in LcV and RPA.
Our study reveals that a1AT and IFN-g counteract
disease-associated upregulation of KC and/or leukocyte
recruitment. Local KC production correlated with
the recruitment of leukocytes. Moreover, a1AT directly
interfered with KC function in chemotaxis. Thus, our
data clearly demonstrate that application of a1AT and
IFN-g reduces the severity of ICV.
RESULTS
a1AT reduced RPA-related neutrophil influx and edema
Endogenous-derived a1AT was recently described as a
modulator of IC-mediated diseases (Bergin et al., 2010).
Therefore, we hypothesized that a1AT might be an
endogenous suppressor of LcV. First, we investigated the
influence of a1AT on the early (4 hours) and late (8 hours)
response in a murine model of LcV. Macroscopic analysis
revealed a reduction of edema formation (Figure 1a), and
histological examination showed reduction of leukocyte
recruitment (Figure 1b; mainly neutrophils, Figure 1c; also
see Discussion) in RPA skin lesions at 4 hours. We found
that a1AT reduced neutrophil recruitment as measured by
myeloperoxidase (MPO) activity from 13.7±0.1 to
8.0±0.05 mU and from 9.7±0.1 to 5.7±0.2 mU at 4 and
8 hours, respectively (Figure 1d). Edema formation as
measured by the increase in biopsy weight was significantly
reduced by a1AT at 4 hours (from 14.5±0.9 to 11.6±1 mg;
Figure 1d). In turn, at 8 hours, no significant reduction of
biopsy weight was measured (Figure 1d). To further
underline the specificity of the IC formation, control
experiments were conducted. Supporting our previous
data (Goerge et al., 2008), anti-BSA/BSA complex forma-
tion determined the severity of the RPA reaction.
Intradermal injection of IgG instead of anti-BSA did not
lead to edema formation (no Evans blue leakage and no
biopsy weight increase) and leukocyte recruitment
(Supplementary Figure S1a and b online). In addition,
the applied ratio of anti-BSA/BSA induced no overt
hemorrhage even after 8 hours (Supplementary Figure
S1c and d online). The detected neutrophils are then
secondary to active recruitment and not the consequence
of passive vessel leakage.
In summary, a1AT reduces the severity of ICV.
Intravital microscopy (IVM) showed decreased intravascular
neutrophil adhesion in a1AT-treated mice
To obtain a more detailed understanding of how a1AT
interfered with leukocyte recruitment in RPA, we performed
IVM. The dorsal skinfold chamber (DSC) is an ideal tool for
continuous observation of the inflammatory response in the
cutaneous microcirculation in vivo. Therefore, anti-BSA
antibody was injected intradermally and the recruitment of
fluorescently labeled leukocytes was observed for up to
8 hours. A representative experiment is shown in Figure 2a.
We found that a1AT reduced recruitment of neutrophils
during RPA at all investigated time points (Figure 2a). At
1 hour, quantification revealed a significant reduction of
intravascular adherent leukocytes in a1AT-treated mice to
100±19 cells per mm2 vessel as compared with 241±42
cells per mm2 vessel (Figure 2b). It is noteworthy that there
was no obvious reduction in leukocyte rolling, indicating that
a1AT exerts its anti-inflammatory effect downstream of
rolling. Moreover, in a1AT-treated mice, substantially re-
duced numbers of extravasated leukocytes (180±27 cells per
mm2 tissue) were detected as compared with vehicle-treated
mice (471±46 cells per mm2 tissue; Figure 2c).
Together, our data indicate that a1AT strongly interferes
with leukocyte adhesion during RPA.
a1AT impaired neutrophil recruitment by interference
with KC function
Previously, it has been shown that IL-8- and IC-mediated
chemotaxis is impaired by a1AT (Bergin et al., 2010). Here, we
investigated whether a1AT might interfere with KC-mediated
neutrophil recruitment during RPA. Although a1AT
(4.0±0.05 mU) and KC blocking (4.2±0.1 mU) both led to a
significant reduction of neutrophil recruitment during RPA as
compared with vehicle (7.1±0.2 mU), their combination did
not further reduce leukocyte influx (3.2±0.05 mU; Figure 3a).
Moreover, in an in vivo chemotaxis assay, intradermal KC
injection led to a dose-dependent recruitment of neutrophils,
which is significantly reduced by 39±6% through a1AT
(Figure 3b and c). Furthermore, we also investigated the
phenomenon of a1AT-downregulated KC chemotaxis using
IVM. After intradermal KC injection, neutrophil influx was
tracked continuously for 2 hours in the DSC. Again, at all
investigated time points, a1AT decreased the number of
recruited leukocytes. a1AT reduced leukocyte numbers per
4 mm2 tissue from 112±14, 444±48, 898±128, and 1129±
143 in vehicle-treated mice to 48±8, 155±10, 262±33, and
393±58 at 5, 30, 60, and 120 minutes, respectively (Figure 4a
and b). Calcium mobilization studies revealed that KC elicited
a rapid increase of intracellular calcium levels, which was
reduced by pretreatment with a1AT (Figure 3d).
In summary, a1AT reduce neutrophil recruitment through
impairment of KC function.
Infiltrating neutrophils further contributed to KC expression
in RPA
As shown in Figure 3, KC plays a major role for leukocyte
recruitment in RPA. KC upregulation might be due to
elevated KC expression by the inflamed tissue or through
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infiltrating neutrophils. Therefore, we investigated the con-
tribution of infiltrating neutrophils to the expression of KC
using a blocking antibody to CD18 that prevents neutrophil
extravasation. Expectedly, blockade of CD18 strongly re-
duced neutrophil recruitment and edema formation, whereas
the isotype control antibody did not influence neutrophil
recruitment or edema at the 4-hour time point (Figure 5a and
b). MPO activity was 6.0±0.1 mU in mice that received
vehicle and 5.2±0.1 mU in mice that received isotype
control antibody. Injection of CD18-blocking antibody
decreased neutrophil influx by 75% (to 1.3±0.07 mU) as
compared with mice treated with isotype control antibody
(Figure 5b). Moreover, in mice treated with vehicle or isotype
control antibody, biopsy weight increased by 16.25±3.5 and
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Figure 1. The a-1-antitrypsin (a1AT) decreased the severity of reverse passive Arthus reaction (RPA). Injection of a1AT significantly decreased neutrophil
recruitment and edema during RPA. (a) Representative pictures demonstrated that edema (blue spots) was reduced and (b) that leukocyte recruitment was
decreased in mice pretreated with a1AT. Arrows indicate regions with severe leukocyte influx, and arrowheads point to the region with reduced leukocyte
influx. (c) To identify neutrophils (green arrow heads) as the infiltrating cell type in RPA lesions, a representative detailed picture is shown. (d) The
myeloperoxidase (MPO) quantification revealed that a1AT reduced neutrophil influx by 42 and 41% at 4 and 8 hours, respectively, after RPA was induced.
Edema formation was decreased by B21% in mice that were pretreated with a1AT at 4 hours, whereas edema was unaffected by a1AT at a later time point.
(b) Bar¼200 mm. Results are presented as mean values±SEM of at least n¼5 mice per group. *Po0.05; **Po0.01; ***Po0.005. HS, healthy skin;
NS, not significant. Mann–Whitney rank sum test (c).
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15.5±1.4 mg, respectively, as compared with 4.5±0.7 mg
after injection of the CD18-blocking antibody (Figure 5a and
b). In mice treated with CD18-blocking antibody, the edema
was significantly reduced by B3-fold. This was further
supported by macroscopic examination of Evans blue leakage
that was apparently reduced in mice treated with CD18-
blocking antibody (Figure 5a).
Next, we investigated the KC mRNA expression level in
these mice. At 4 hours, RPA induced a 39±9-fold upregulation
of KC mRNA expression in vehicle-treated mice as compared
with healthy skin (Figure 5b). Induction of RPA in mice that
received an isotype control antibody or CD18-blocking
antibody enhanced KC mRNA expression by 22±4-fold or
11±1.5-fold, respectively, as compared with their healthy skin
controls (Figure 5b). Although isotype control antibody applied
before RPA induction did not significantly affect KC expres-
sion, blockade of CD18 reduced RPA-related KC expression by
B4-fold compared with vehicle-treated mice.
At the protein level, we measured a significantly reduced
concentration of KC when leukocyte recruitment was inhibited
by a1AT. Reduced neutrophil recruitment (Figure 1c) correlated
with decreased local KC protein following a1AT treatment
(Figure 5c).
In summary, neutrophils are not the exclusive source of
KC during RPA; however, infiltrating neutrophils contribute
substantially to the full induction of KC expression.
IFN-c decreased neutrophil recruitment during cutaneous RPA
A precise role for IFN-g in the pathogenesis of RPA, and its
ability to modify the inflammatory response, remains
unexplored. To investigate the in vivo role of IFN-g
application in ICV, we treated wild-type mice intravenously
(i.v.) with IFN-g or vehicle for 24 hours before RPA was
induced. IFN-g treatment significantly reduced neutrophil
recruitment by 38% as compared with vehicle controls
at 4 hours (Figure 6a and b). Specifically, neutrophil
MPO activity decreased from 7.6±0.7 mU (vehicle) to
4.7±0.5 mU (IFN-g; Figure 6b, black columns). Biopsy
punch weight and total leukocyte count were unaffected
after IFN-g challenge (data not shown). Histological
analysis further confirmed reduced leukocyte recruitment in
mice (Figure 6a). Similar results were obtained for locally
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Figure 2. The a-1-antitrypsin (a1AT) downregulated leukocyte adhesion during reverse passive Arthus reaction (RPA). Following surgical preparation
of the dorsal skinfold chamber, the RPA was induced within the viewfield of the skinfold chamber. To quantify cell migration, mice received intravenous
(i.v.) calcein-labeled bone marrow cells (BMCs). (a) Microscopic examination demonstrated that a1AT significantly decreased the adhesion of calcein-labeled
cells to vessels. (b) At the 1-hour time point, counting of intravascular leukocytes revealed a 2.4-fold reduction in mice that received a1AT. (c) Quantification
of extravasated cells showed that a1AT reduced the number of extravascular leukocytes from 471±46 cells per mm2 tissue in vehicle-treated mice to 180±27
cells per mm2 tissue at 4 hours after RPA was induced. (a) Bar¼ 2 mm. (b, c) *Po0.05; ***Po0.005; Student’s t-test.
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administered IFN-g at the time when RPA was induced.
Intradermal IFN-g decreased MPO activity by B27% as
compared with control at 4 hours (Figure 6b, gray columns).
IFN-g decreased RPA-induced KC mRNA expression 3-
fold (data not shown). Therefore, we next investigated
whether IFN-g-mediated reduction of neutrophil recruitment
might be due to decreased KC protein levels in vivo using KC-
neutralizing antibodies at 4 hours. Injection of KC-neutraliz-
ing antibody reduced neutrophil recruitment by 43±11% to
4.0±0.8 mU as compared with vehicle-treated wild-type
mice (6.9±0.6 mU; Figure 6c). IFN-g treatment reduced
MPO activity to 4.6±0.4 mU. Interestingly, the combination
of IFN-g and KC neutralization further downregulated
neutrophil recruitment to 1.5±0.4 mU (Figure 6c). In
contrast, treatment with IgG2A isotype control antibody did
not affect neutrophil recruitment (data not shown). Our data
indicated that the IFN-g-mediated reduction of neutrophil
recruitment was independent of KC. This was further
confirmed by the finding that IFN-g administration did not
decrease KC protein level in RPA lesions (Figure 6d).
Together, our results therefore show that both local
(simultaneously with disease induction) and systemic (before
disease induction) IFN-g significantly decreased RPA-induced
inflammation through a KC-independent mechanism.
DISCUSSION
Here we show that both a1AT and IFN-g suppressed
neutrophil recruitment in ICV. Although IFN-g exerted its
protective role independent of KC, we observed that
a1AT directly interfered with KC function. IVM revealed that
a1AT impaired KC-mediated leukocyte recruitment in RPA.
Thus, our study identifies IFN-g and a1AT as potent
modulators of ICV.
LcV, the most frequent cutaneous vasculitis, is often self-
limited. This might be due to discontinuation of the trigger
factor or by the induction of endogenous immune regulatory
mechanisms. a1AT is a serine protease inhibitor and
possesses anti-inflammatory activity (Pott et al., 2009).
Recently, regulation of neutrophil chemotaxis through human
a1AT was demonstrated (Pott et al., 2009; Bergin et al.,
2010). Our study was conducted using human a1AT. Both
murine and human a1AT show homology and preservation of
functional structures (Sifers et al., 1990). Moreover, human
a1AT was used in mice and was found to be functional (Song
et al., 2004; Lu et al., 2006; Zhang et al., 2007). During ICV,
a1AT reduced vascular permeability, edema formation, and
leukocyte recruitment (Figure 1). However, these findings
were derived from end-point tissue analysis after 4 and
8 hours and, ignoring the dynamics, do not exclude the
possibility of, e.g., passive leakage of leukocytes into the
surrounding tissue during RPA. Although at the applied
amount of anti-BSA antibody for IC formation (86.8 mg per
spot) we induced no overt hemorrhage at 4 and 8 hours (up to
48 hours; data not shown), we applied IVM for further
studying the dynamics of leukocyte recruitment during RPA.
The DSC is a powerful tool for the continuous visualization of
leukocyte recruitment in the cutaneous microcirculation (Jain
et al., 2002; Goerge et al., 2008). Fluorescently labeled bone
marrow–derived leukocytes from wild-type donor mice were
transferred and the RPA was induced in the DSC. A weakness
of this approach that might affect the interpretation of our
data is that by using unpurified bone marrow–derived
leukocytes, not only neutrophils are transferred into the
recipient mouse. It is also noteworthy that unlabeled
leukocytes from the recipient mouse remain undetected by
this model. However, as for the infiltrating cell type, we
could delineate in preliminary experiments that neutrophils
are the first and major cell type to be recruited in RPA
(depleting anti-Ly6G antibody) and exclude a role for
lymphocytes (NSG mice and CD4 immunofluorescence
stainings; data not shown). As shown in Figure 2, RPA led
to a rapid recruitment of bone marrow–derived leukocytes
(15 minutes), which peaked at 4 hours. At later time points,
bone marrow–derived leukocytes extravasated to the sur-
rounding tissue. Because of tissue swelling, extravasated cells
cannot be imaged at the same resolution. However, all
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Figure 3. The a-1-antitrypsin (a1AT) decreased KC-mediated chemotaxis.
(a) Mice received the indicated treatment before reverse passive Arthus
reaction (RPA) was induced. The myeloperoxidase (MPO) activity in skin
biopsies was measured. Both a1AT- and KC-neutralizing antibodies
significantly reduced neutrophil recruitment. Combined application of
a1AT and KC did not induce stronger effect than both agonists alone.
(b) KC induced a dose-dependent influx of neutrophils after intradermal (i.d.)
application. (c) Injection of a1AT interfered with KC (1 mg)-dependent
neutrophil recruitment into the mouse skin. (d) Bone marrow neutrophils
were isolated and intracellular calcium mobilization was measured
following KC stimulation in the presence or absence of a1AT. Preincubation
(2 minutes) with a1AT reduced KC-elicited calcium release in bone marrow
neutrophils. *Po0.05; ***Po0.005; NS, not significant; (a) two-way or
(b) one-way analysis of variance (ANOVA) with post hoc Tukey’s test,
(c) Student’s t-test.
2290 Journal of Investigative Dermatology (2012), Volume 132
M Feld et al.
Regulators of LcV and RPA
leukocytes followed the known recruitment machinery of
rolling, firm adhesion, and transmigration, and did not leak
passively into the tissue. a1AT treatment reduced neutrophil
recruitment at all observed time points, whereas we did not
see any reduced rolling. This observation suggests that a1AT
did not impede the inflammatory response per se, but
diminished its overall response. A putative explanation might
be a reduction of chemotaxis during RPA. Indeed, Bergin
et al. (2010) showed that a1AT binds IL-8 and we observed in
mice that KC is upregulated during RPA (Figure 5c). To
support the hypothesis that a1AT interfered with the
chemotactic function of KC, several experiments were
conducted. In the DSC, we observed that intradermal KC
injection led to robust neutrophil recruitment within 2 hours.
As shown, a1AT significantly reduced this KC-mediated
leukocyte recruitment (Figures 3 and 4). In addition, KC
blocking reduced leukocyte recruitment in RPA, which was
not further reduced by a1AT (Figure 3a). In line with these
findings, KC-dependent neutrophil activation in calcium
mobilization studies was significantly reduced by a1AT.
Although the cellular source of KC and the kinetics of KC
production during RPA were not investigated, we observe
that a1AT reduced the severity of RPA, presumably through
interference with KC function.
To further elucidate the role of KC in ICV, we addressed
the regulation of KC in RPA. Our study revealed that
infiltrating neutrophils critically contribute to KC expression.
During inflammation, local KC levels can be elevated
through invading neutrophils that express KC or through
resident cells in the inflamed tissue (Armstrong et al., 2004).
As shown previously (Sindrilaru et al., 2007), b2-integrin
knockout significantly reduces RPA (Figure 3a and b).
Interestingly, blockade of neutrophil recruitment by a b2-
integrin blocking antibody significantly reduces KC expres-
sion, suggesting that KC expression during RPA critically
depends on neutrophils. Indeed, neutrophil depletion re-
duced KC in an air pouch model or after surgical injury
(Endlich et al., 2002; Garcı´a-Ramallo et al., 2002). In
contrast, in a model of LPS-induced lung injury, it was
demonstrated that neutrophil depletion may also account for
KC elevation (Aggarwal et al., 2009). These contradictive
findings suggest a context-dependent regulation of KC during
inflammation. For ICV, we demonstrate that KC expression
substantially depends on neutrophil recruitment.
Previous works could show that IFN-g may have different
roles for KC regulation and in IC-mediated diseases.
Depending on the disease model and phase of inflammation,
different findings had been reported (Flesch et al., 1998;
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Figure 4. Visualization of a-1-antitrypsin (a1AT)-dependent reduction of leukocyte recruitment in response to KC. Following surgical preparation of the dorsal
skinfold chamber, KC was intradermally (i.d.) injected within the viewfield of the skinfold chamber. To visualize cell recruitment, mice received intravenous
(i.v.) calcein-labeled bone marrow cells (BMCs). The reverse passive Arthus reaction (RPA) was monitored at the indicated time points. (a) Microscopic
examination revealed a decreased recruitment of BMCs in response to KC. (b) Counting of intravascular cells revealed significant reduction in mice that received
a1AT at 30, 60, and 120 minutes after KC injection. (a) Bar¼ 2 mm. (b) ***Po0.005; Student’s t-test.
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Nabbe et al., 2003; Ishida et al., 2004; Boost et al., 2008). On
investigating the role of IFN-g in RPA, we observed reduced
neutrophil recruitment after both pretreatment and simulta-
neous administration of IFN-g. In contrast to a1AT, the
observed reduced neutrophil recruitment through IFN-g was
independent of KC. IFN-g challenge did not affect KC
expression at the protein level (Figure 6d), and concomitant
application of KC-blocking antibody and IFN-g further
diminished neutrophil recruitment compared with the single
application, further suggesting KC independence. Apart from
KC, a participation of other pro-inflammatory chemokines
and their regulation through IFN-g is likely. It is noteworthy
that IFN-g downregulates mycobacteria-induced granulocyte
chemotactic protein-2 upregulation in keratinocytes, and,
moreover, in an in vivo arthritis model, deletion of endo-
genous IFN-g was accompanied by granulocyte chemotactic
protein-2 elevation (Kelchtermans et al., 2007), indicating a
regulatory role for IFN-g in neutrophil recruitment.
In sum, our study on mice provides in vivo evidence for an
anti-inflammatory role of IFN-g and a1AT in experimentally
induced LcV. Moreover, it may be hypothesized that
administration of a1AT in humans may be even more
beneficial as other protective functions beyond regulation
of KC function in ICV exist. For example, a1AT prevented
binding of anti-PR3 antibodies to neutrophils in Wegener’s
granulomatosis, a non-ICV, and thereby reduced neutrophil
activation (Rooney et al., 2001). Our study may provide a
previously unreported strategy for the pharmacological
treatment of LcV.
MATERIALS AND METHODS
Materials
Human a1AT was from Sigma Aldrich (Mu¨nchen, Germany), and
murine recombinant IFN-g and murine KC were purchased from
Peprotech (Hamburg, Germany). Human a1AT was used at a
concentration of 50mg g1 mouse. IFN-g was used at a concentration
of 0.125 or 0.5mg g1 mouse to stimulate mice simultaneously with or
before RPA induction, respectively. The following antibodies were
used: rat anti-mouse KC (R&D Systems, Wiesbaden-Nordenstadt,
Germany), rat anti-mouse CD18 (BD Pharmingen, Heidelberg,
Germany), rabbit anti-BSA, rabbit IgG from serum (Sigma Aldrich),
and rat IgG1 (BD Biosciences, Heidelberg, Germany). BSA was
obtained from PAA Laboratories (Co¨lbe, Germany). Evans blue, MPO,
and Fura-2 acetoxymethyl were from Sigma Aldrich. Cell culture
reagents were purchased from PAA.
Mice
C57BL/6J male mice, 6 to 8 weeks old, were purchased from the Harlan
Laboratories (Horst, The Netherlands). All experiments were conducted
according to institutional regulations (Office for the Environment,
Nature and Municipal Affairs of North Rhine-Westphalia).
Preparation of murine neutrophils from bone marrow
Femurs and tibiae from the hind legs were removed and flushed with
phosphate-buffered saline supplemented with 1% fetal calf serum
and 2 mM EDTA. After dispersing cells, erythrocytes were lysed in
155 mM ammonium chloride, 10 mM potassium bicarbonate, and
0.1 mM EDTA (pH 7.3). The reaction was stopped by adding 1
volume of MEM supplemented with 10% fetal calf serum, 1%
penicillin/streptomycin, and 1% nonessential amino acids, and the
remaining cells were spun down. Neutrophils were isolated using
the anti-Ly-6G MicroBead Kit (Miltenyi Biotech, Bergisch Gladbach,
Germany) according to the manufacturer’s instructions.
In vivo ICV
As we published previously (Goerge et al., 2008), the RPA was
induced by i.v. injection of BSA (150 ml 1% BSA/phosphate-buffered
saline per 20 g mouse), immediately followed by subcutaneous
injection of 20ml anti-BSA antibody or whole IgG from rabbit (each
4.34 mg ml1). To follow the intensity of vascular leakage, 50 ml 1%
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Figure 5. Lesional leukocyte influx was a prerequisite for full KC induction.
Mice were treated with vehicle, isotype control antibody, or CD18-
blocking antibody before reverse passive Arthus reaction (RPA) was induced.
(a) For each treatment, a representative picture is shown. Intensity of blue
spots indicates edema. (b) Skin biopsies from mice were weighed and
myeloperoxidase (MPO) was measured. Neutrophil recruitment and biopsy
weight were practically equal in mice that received vehicle and those that
received isotype control antibody. Expectedly, CD18 blockade significantly
decreased leukocyte influx and edema at 4 hours. (c) In vehicle-treated mice,
RPA induction increased KC mRNA expression at 4 hours. Application of
isotype control antibody did not significantly reduce KC mRNA expression
during RPA. In contrast, injection of CD18-blocking antibody substantially
reduced RPA-related induction of KC mRNA expression. (d) In a-1-antitrypsin
(a1AT)-treated mice, the observation of reduced leukocyte influx (Figure 2)
was correlated with reduced KC protein levels at 4 hours. Results are
presented as mean values±SEM of at least n¼ 9–10 mice per group.
*Po0.05; ***Po0.005. HS, healthy skin; NS, not significant. Analysis of
variance (ANOVA) on ranks with post hoc Student–Newman–Keuls test
(b, KC expression) or with post hoc Dunn’s test (b, MPO and edema), and
(c) Student’s t-test.
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Evans blue per 20 g mouse was injected i.v. To visualize erythema,
Evans blue was omitted and substituted with phosphate-buffered
saline. Mice were treated with a1AT 2 hours before RPA induction.
IFN-g was applied in two different modes: 24 hours before or
simultaneously with induction of the RPA. Mice received 25mg anti-
CXCL1/KC antibody per mouse 24 hours before RPA was induced. A
second dose of anti-CXCL1/KC (50mg per mouse) was given with
induction of RPA. To block leukocyte adhesion, mice received 75mg
anti-CD18 or isotype control antibody (i.v.) at the time when RPA
was induced. Mice were killed 4 or 8 hours after RPA was induced,
and skin biopsies (6 mm punches) were harvested and weighed.
Biopsies were homogenized and analyzed for MPO activity. In
addition, samples (8 mm punches) for RNA and protein preparations
were collected.
In vivo imaging of leukocyte recruitment
C57BL/6 mice were anesthetized by intraperitoneal injection of
ketamine (80 mg kg1; Ceva, Du¨sseldorf, Germany) and xylazine
(14 mg kg1; Ceva), and surgical preparation of DSCs was performed
as described previously (Goerge et al., 2008). Mice were allowed to
recover from surgery for 24 hours. For in vivo microscopic
observations, the skinfold chamber preparation was attached to the
microscope stage and IVM was performed on an epifluorescence
microscope (AxioImagerZ2; Zeiss, Hamburg, Germany) using  2.5
and  10 magnification objectives. Before IVM was performed in
the DSC, 3 107 bone marrow cells, extracted from C57BL/6 donor
mice, were labeled with calcein green (5 mg ml1; Invitrogen,
Darmstadt, Germany) and transferred into recipient mice by tail
vein injection. Mice were treated with a1AT or vehicle 2 hours
before RPA or intradermal KC treatment was initiated. Leukocyte
recruitment was recorded by attached cameras (AxioCam MRm/
AxioCam MRc; Zeiss), and data acquisition was performed using the
AxioVision software (version 4.8; Zeiss). For RPA experiments, the
numbers of intravascular cells in relation to the vessel diameter, as
well as extracellular neutrophils, were counted. For KC experiments,
recruited cells per 4 mm2 tissue were determined.
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Figure 6. IFN-c decreased leukocyte recruitment during reverse passive Arthus reaction (RPA), but independent of KC. Application of IFN-g before RPA
induction decreased leukocyte recruitment into RPA lesions in mice. (a) Representative hematoxylin and eosin (H&E) stainings from sections of skin biopsies
from mice that were pretreated with IFN-g or vehicle are depicted. Arrows indicate regions with strong leukocyte invasion. (b) At 4 hours after RPA was induced,
lesional myeloperoxidase (MPO) activity was markedly reduced in IFN-g-treated mice when applied either as a systemic pretreatment (p, black columns)
for 24 hours or simultaneously with RPA induction (s, gray columns). (c) Both IFN-g- and KC-neutralizing antibodies reduced MPO activity in RPA lesions.
However, combining KC and IFN-g further decreased neutrophil recruitment as compared with both stimuli alone. (d) Although IFN-g strongly downregulated
KC mRNA expression (data not shown), no reduction on KC protein level was detectable in IFN-g-treated mice. (a) Bar¼ 200 mm. Results are presented as mean
values±SEM of at least n¼ 6 mice per group. *Po0.05; **Po0.01. HS, healthy skin; NS, not significant. (b, d) Student’s t-test, (c) two-way analysis of variance
(ANOVA) with post hoc Tukey’s test.
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In vivo chemotaxis assay
Mice were anesthesized and received a1AT (i.v.) or vehicle. After
2 hours, mice were treated with different amounts of KC sub-
cutaneously for 1 hour. Mice were then killed, and skin biopsies
(6 mm punches) were collected and subjected to quantification for
MPO activity.
Analysis of chemokine expression using quantitative real-time
reverse-transcriptase–PCR
Quantification of mRNA steady-state levels of the genes of interest was
performed by real-time fluorescence detection using Absolute SYBR
Green ROX mix (Applied Biosystems, Foster City, CA). Reactions were
carried out in duplicate in an ABI Prism 7,300 sequence detector
supplied with the SDS 2.1 software (Applied Biosystems). Primer
sequences were as follows: murine KC forward, 50-AGAGCTT
GAAGGTGTTGCCCT-30, and reverse, 50-CGCGACCATTCTTGAGTG
TG-30 and murine b-Actin forward, 50-TTGCTGACAGGATGCA
GAAG-30, and reverse, 50-TGATCCACATCTGCTGGAAG-30.
Intracellular calcium mobilization
Isolated neutrophils from bone marrow were loaded with 3.5 mM
Fura-2 acetoxymethyl in HEPES-buffered salt solution (140 mM NaCl,
3 mM KCl, 0.4 mM Na2HPO4, 10 mM HEPES, 5 mM glucose, 1 mM
MgCl2, and 0.8 mM CaCl2, pH 7.4). After washing cells twice in
HEPES-buffered salt solution, KC-elicited calcium mobilization in
2 106 neutrophils was analyzed in a FluoroMaxx spectrophot-
ometer (Yobin Yvon, Bensheim, Germany). Alternatively, cells
were treated with a1AT for 2 minutes and then stimulated with
100 nM KC.
Hematoxylin and eosin staining
Hematoxylin and eosin staining was performed on cryostat sections
of murine skin (3–4 mm) according to standard methods. Photographs
were taken with an Observer.Z1 (Zeiss) and AxioVision 4.8 software.
Statistical analysis
Results are expressed as mean±SEM. At least three independent
experiments were conducted (n43). Statistical analysis was per-
formed using the SigmaPlot 12 software (Systat, Erkrath, Germany).
Significance was evaluated by Student’s t-test, Mann–Whitney rank
sum test, and by one-way and two-way analyses of variance with
post hoc Tukey’s testing unless otherwise stated in the text.
Significance was set at Po0.05.
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